scholarly journals The Effect of Specific Immunotherapy on Natural Killer T cells in Peripheral Blood of House Dust Mite-Sensitized Children with Asthma

2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
Lu Yan-ming ◽  
Cao Lan-fang ◽  
Li Chen ◽  
Li Ya-qin ◽  
Chen Wei ◽  
...  
Keyword(s):  
House Dust ◽  
House Dust Mite ◽  
Peripheral Blood ◽  
Specific Immunotherapy ◽  
Mononuclear Cells ◽  
Nkt Cells ◽  
Control Group ◽  
Peripheral Blood Mononuclear ◽  
Dust Mite ◽  
Asthma Group

To investigate the effects of specific immunotherapy on the NKT cells in peripheral blood and the ability of NKT cells to proliferate in response to alpha-galactosylceramide (alpha-GalCer) in house-dust-mite- (HDM-) sensitized asthma children, peripheral blood mononuclear cells were isolated from 42 asthmatic children, of whom 24 were on specific immunotherapy (SIT) for more than a year and 20 were healthy. Compared with control group, the ratio of peripheral blood NKT and CD4+NKT cells was significantly decreased (P<0.01) and was elevated in SIT asthma group (P<0.05), respectively, but it was still less than the normal control group (P<0.01). The level of IL-4 in serum secreted by NKT cells in asthma group was significantly higher than that of control group (P<0.01), particularly apparent after 72 hours. The level of IL-4 in SIT group decreased significantly (P<0.01). The level of IL-10 in serum secreted by NKT cells in asthma group was decreased significantly than that of the control group (P<0.01) especially in 48 hours, while that of SIT group was increased significantly (P<0.01). These results suggest that the pathogenesis of asthma may be related to the ratio and dysfunction of NKT and CD4+NKT cells.

scholarly journals Antibody blockade of Dectin-2 suppresses house dust mite-induced Th2 cytokine production in dendritic cell- and monocyte-depleted peripheral blood mononuclear cell co-cultures from asthma patients

2019 ◽  
Vol 26 (1) ◽  
Author(s):  
Ming-Han Chen ◽  
Ming-Ting Huang ◽  
Wen-Kuang Yu ◽  
Shinn-Shing Lee ◽  
Jia-Horng Wang ◽  
...  
Keyword(s):  
House Dust ◽  
House Dust Mite ◽  
Peripheral Blood ◽  
Mononuclear Cells ◽  
Specific Binding ◽  
Dependent Manner ◽  
Peripheral Blood Mononuclear ◽  
Dust Mite ◽  
Der P 2

Abstract Background Dectin-2, which is a C-type lectin, interacts with the house dust mite (HDM) Dermatophagoides pteronyssinus allergen. This study aimed to investigate whether Dectin-2 blockade by antagonistic monoclonal antibodies (MoAbs) attenuates HDM-induced allergic responses. Methods Two anti-Dectin-2 MoAbs were generated and validated for specific binding to Dectin-2 Fc fusion protein (Dectin-2.Fc) and inhibition of Dectin-2.Fc/HDM interaction. Patients with asthma exhibiting high titers of anti-D. pteronyssinus IgE were enrolled. Peripheral blood mononuclear cells with depleted CD14+ monocytes were obtained from these patients and co-cultured with autologous monocyte-derived conventional dendritic cells in the presence of D. pteronyssinus or its group 2 allergens (Der p 2). Interleukin (IL)-5 and IL-13 levels in the culture supernatants were determined using ELISA in the presence or absence of anti-Dectin-2 MoAbs. Results Two MoAbs, 6A4G7 and 17A1D10, showed specific binding to recombinant Dectin-2.Fc and inhibited HDM binding to Dectin-2.Fc. Both anti-Dectin-2 MoAbs inhibited IL-5 and IL-13 production in co-cultures with Der p 2 stimulation in a dose-dependent manner. 6A4G7 and 17A1D10 (3 μg/mL) significantly inhibited Der p 2-induced (3 μg/mL) IL-5 production by 69.7 and 86.4% and IL-13 production by 84.0 and 81.4%, respectively. Moreover, this inhibitory effect of the two MoAbs remained significant in the presence of D. pteronyssinus. Conclusions Anti-Dectin-2 MoAbs significantly inhibited HDM-induced allergic responses in vitro and therefore have the potential to become therapeutic agents in mite-induced allergic diseases.

scholarly journals Enhanced Cysteinyl-Leukotriene Type 1 Receptor Expression in T Cells from House Dust Mite-Allergic Individuals following Stimulation with Der p

2015 ◽  
Vol 2015 ◽  
pp. 1-11 ◽  
Author(s):  
Maryse Thivierge ◽  
Sylvie Turcotte ◽  
Marek Rola-Pleszczynski ◽  
Jana Stankova
Keyword(s):  
T Cells ◽  
T Cell ◽  
House Dust ◽  
House Dust Mite ◽  
Cell Activation ◽  
Mononuclear Cells ◽  
Receptor Expression ◽  
Peripheral Blood Mononuclear ◽  
Dust Mite ◽  
Cell Expression

In order to determine the potential for allergen to modulate T cell expression of the CysLT1receptor and responsiveness to leukotrienes, peripheral blood mononuclear cells from house dust mite-allergic or nonallergic individuals were incubated withD. pteronyssinusallergen (Der p). Baseline CysLT1expression was similar in both groups of donors, but Der p significantly enhanced CysLT1expression in CD4+and CD8+T cells of only allergic individuals and induced enhanced responsiveness of CD4+T cells to LTD4in terms of calcium mobilisation. This effect was prevented by the CysLT1antagonist MK571. Der p also induced IL-4 and IL-10 production, and neutralizing antibody to IL-4 prevented both the enhanced CysLT1expression and the enhanced responsiveness of T cells to LTD4induced by Der p. In allergic individuals, Der p also induced T cell proliferation and a Th2-biased phenotype. Our data suggest that, in allergen-sensitized individuals, exposure to allergen can enhance T cell expression of CysLT1receptors through a mechanism involving IL-4 production. This, in turn, would induce CD4+T cell responsiveness to cysteinyl-leukotrienes and Th2 cell activation.

scholarly journals Autologous Peripheral Blood Mononuclear Cells for Limb Salvage in Diabetic Foot Patients with No-Option Critical Limb Ischemia

2021 ◽  
Vol 10 (10) ◽  
pp. 2213
Author(s):  
Alessia Scatena ◽  
Pasquale Petruzzi ◽  
Filippo Maioli ◽  
Francesca Lucaroni ◽  
Cristina Ambrosone ◽  
...  
Keyword(s):  
Peripheral Blood Mononuclear Cells ◽  
Critical Limb Ischemia ◽  
Diabetic Foot ◽  
Peripheral Blood ◽  
Mononuclear Cells ◽  
Limb Ischemia ◽  
Control Group ◽  
Peripheral Blood Mononuclear ◽  
Blood Mononuclear Cells

Peripheral blood mononuclear cells (PBMNCs) are reported to prevent major amputation and healing in no-option critical limb ischemia (NO-CLI). The aim of this study is to evaluate PBMNC treatment in comparison to standard treatment in NO-CLI patients with diabetic foot ulcers (DFUs). The study included 76 NO-CLI patients admitted to our centers because of CLI with DFUs. All patients were treated with the same standard care (control group), but 38 patients were also treated with autologous PBMNC implants. Major amputations, overall mortality, and number of healed patients were evaluated as the primary endpoint. Only 4 out 38 amputations (10.5%) were observed in the PBMNC group, while 15 out of 38 amputations (39.5%) were recorded in the control group (p = 0.0037). The Kaplan–Meier curves and the log-rank test results showed a significantly lower amputation rate in the PBMNCs group vs. the control group (p = 0.000). At two years follow-up, nearly 80% of the PBMNCs group was still alive vs. only 20% of the control group (p = 0.000). In the PBMNC group, 33 patients healed (86.6%) while only one patient healed in the control group (p = 0.000). PBMNCs showed a positive clinical outcome at two years follow-up in patients with DFUs and NO-CLI, significantly reducing the amputation rate and improving survival and wound healing. According to our study results, intramuscular and peri-lesional injection of autologous PBMNCs could prevent amputations in NO-CLI diabetic patients.

Sign in / Sign up

Export Citation Format

Share Document